You are here: Industry Insights > AI

News List

What To Expect in the 2024 Pharmaceutical Market Suzanne Elvidge
January 12, 2024
The pharmaceutical market is growing fast. According to Statista.The largest market is oncology, predicted to be worth US$214.10 billion in 2024.
Advancements in scientific technologies to Drug discovery and Development 2023 Shruti Talashi
January 02, 2024
Technological advancement apart from a deeper comprehension of disease biology, and an emphasis on breaking down conventional boundaries is driving this era of profound change in the drug development industry.
MNC ramps up AI pharmaceutical layout, can AI and pharmaceuticals collide to spark "fireworks"? Yefenghong/PharmaSources
October 27, 2023
AI (Artificial Intelligence) pharmaceuticals refer to the use of artificial intelligence technologies such as big data, cloud computing, and deep learning to assist in drug discovery, drug management, efficacy analysis, and other processes.
Traditional drug manufacturing is evolving into Bio-foundry : A long way to go! Shruti Talashi
August 08, 2023
Pharmaceutical industries are changing their approach to drug discovery, the new in trend is bio-manufacturing based on bio-foundry model approach.
AI powers drug R&D OpenAI technology promises a new technological revolution PharmaSources
April 27, 2023
With the development of technology, AI technology has been widely used in several medical field scenarios.
Pharma Sources Insight April 2023: Innovative Drugs Going Abroad Pharma Sources Insight
April 18, 2023
A look into the innovative drugs R&D and emerging market.
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology PR Newswire
January 10, 2025
Jan 10, 2025: Menarini Group, its subsidiary Stemline, and Insilico Medicine ink an exclusive license deal. Stemline gets global rights for a pre - clinical oncology small - molecule addressing high unmet needs.
BRIDGING CLINICAL RESEARCH AND CLINICAL CARE WITH AI-AIDING PATHOLOGISTS TOOL PR Newswire
December 09, 2024
The National Institutes of Health (NIH) and a panel of distinguished international liver pathologists showcased how Artificial Intelligence (AI) is revolutionizing the evaluation of liver fibrosis in metabolic dysfunction-associated steatohepatitis (MASH)
Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA PharmaSources
May 17, 2024
The expanded collaboration includes increasing adoption of the NVIDIA Clara suite of AI-powered computing platforms, software, and services in the Sartorius ecosystem.
First Study Using Biomimetic AI Digital Twins And Multiomics in Genetics Research PharmaSources
April 07, 2024
The Application of Knowledge Engineering via the use of a Biomimetic Digital Twin Ecosystem, Phenotype DrivenVariant Analysis, and Exome Sequencing to Understand the Molecular Mechanisms of Disease.